The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Final Results of the 94–01 French Head and Neck Oncology and Radiotherapy Group Randomized Trial Comparing Radiotherapy Alone With Concomitant Radiochemotherapy in Advanced-Stage Oropharynx Carcinoma
Abstract
Purpose: We report the 5-year survival and late toxicity results of a randomized clinical trial, which showed a 3-year improvement in overall survival and locoregional control of stage III or IV oropharynx carcinoma, using concomitant radiochemotherapy (arm B), compared with standard radiotherapy (arm A). Patients and Methods: A total of 226 patients were entered onto a phase III multicenter randomized trial comparing radiotherapy alone (70 Gy in 35 fractions; arm A) with concomitant radiochemotherapy (70 Gy in 35 fractions with three cycles of a 4-day regimen comprising carboplatin and fluorouracil; arm B). Prognostic factors were evaluated by univariate and multivariate analysis. Five-year late toxicity was evaluated using National Cancer Institute Common Toxicity Criteria for neurological toxicity, hearing, taste, mandibula, and teeth damage, and Radiation Therapy Oncology Group toxicity criteria for skin, salivary gland, and mucosa. Results: Five-year overall survival, specific disease-free survival, and locoregional control rates were 22% and 16% (log-rank P = .05), 27% and 15% (P = .01), and 48% and 25% (P = .002), in arm B and arm A, respectively. Stage IV, hemoglobin level lower than 125 g/L, and standard treatment were independent prognostic factors of short survival and locoregional failure by univariate and multivariate analysis. One or more grade 3 to 4 complications occurred in 56% of the patients in arm B, compared with 30% in arm A (P was not significant). Conclusion: Concomitant radiochemotherapy improved overall survival and locoregional control rates and does not statistically increase severe late morbidity. Anemia was the most important prognostic factor for survival in both arms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pignon, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)90011-0 · Cited by 2,543
Parker, S. L., Tong, T., Bolden, S., & Wingo, P. A. (1996) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.46.1.5 · Cited by 1,759
Some necessary conditions for common-factor analysis
Guttman, L. (1954) · Psychometrika · doi:10.1007/bf02289162 · Cited by 1,689
Brizel, D. M., Albers, M. E., Fisher, S. R., Scher, R. L., Richtsmeier, W. J., Hars, V., George, S. L., Huang, A. T., & Prosnitz, L. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806183382503 · Cited by 1,127
Calais, G., Alfonsi, M., Bardet, E., Sire, C., Germain, T., Bergerot, P., Rhein, B., Tortochaux, J., Oudinot, P., & Bertrand, P. (1999) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/91.24.2081 · Cited by 1,060
Self-citationVaupel, P. W., Schlenger, K., Knoop, C., & Höckel, M. (1991) · PubMed · Cited by 952
Wendt, T. G., Grabenbauer, G. G., Rödel, C. M., Thiel, H. J., Aydin, H., Rohloff, R., Wustrow, T. P., Iro, H., Popella, C., & Schalhorn, A. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1318 · Cited by 634
Tenenhaus, M., & Young, F. W. (1985) · Psychometrika · doi:10.1007/bf02294151 · Cited by 414
Staar, S., Rudat, V., Stuetzer, H., Dietz, A., Volling, P., Schroeder, M., Flentje, M., Eckel, H. E., & Mueller, R.-P. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01544-9 · Cited by 360
Dose Specification for Reporting External Beam Therapy with Photons and Electrons
Wootton, P. (1979) · Medical Physics · doi:10.1118/1.594621 · Cited by 270
Jeremic, B., Shibamoto, Y., Stanisavljevic, B., Milojevic, L., Milicic, B., & Nikolic, N. (1997) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(97)00048-0 · Cited by 252
Adelstein, D. J., Saxton, J. P., Lavertu, P., Tuason, L., Wood, B. G., Wanamaker, J. R., Eliachar, I., Strome, M., & Van Kirk, M. A. (1997) · Head & Neck · doi:10.1002/(sici)1097-0347(199710)19:7<567::aid-hed2>3.0.co;2-5 · Cited by 245
Hoeller, U., Tribius, S., Kuhlmey, A., Grader, K., Fehlauer, F., & Alberti, W. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04202-5 · Cited by 143
Dubray, B. M., Mosseri, V., Brunin, F., Jaulerry, C., Poncet, P., Rodriguez, J., Brugère, J., Point, D., Giraud, P., & Cosset, J. (1996) · Radiology · doi:10.1148/radiology.201.2.8888257 · Cited by 138
Rudat, V., Stadler, P. F., Becker, A., Vanselow, B., Dietz, A., Wannenmacher, M., Molls, M., Dunst, J., & Feldmann, H. J. (2001) · Strahlentherapie und Onkologie · doi:10.1007/pl00002427 · Cited by 95
Impact of Anemia in Patients With Head and Neck Cancer
Kumar, P. (2000) · The Oncologist · doi:10.1634/theoncologist.5-suppl_2-13 · Cited by 91
Application of the Predictive Value Model in the Analysis of Test Effectiveness
Galen, R. S. (1982) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)31007-2 · Cited by 77
TESTS OF SIGNIFICANCE IN FACTOR ANALYSIS
Burt, C. (1952) · British Journal of Statistical Psychology · doi:10.1111/j.2044-8317.1952.tb00117.x · Cited by 72
Plasma boron and the effects of boron supplementation in males.
Green, N. R., & Ferrando, A. A. (1994) · Environmental Health Perspectives · doi:10.1289/ehp.94102s773 · Cited by 45
ROC curve regression analysis: the use of ordinal regression models for diagnostic test assessment.
Tosteson, A. N. A., Weinstein, M. C., WITTENBERG, J., & Begg, C. B. (1994) · Environmental Health Perspectives · doi:10.1289/ehp.94102s873 · Cited by 33
Cited by
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
Bonner, J. A., Harari, P. M., Giralt, J., Azarnia, N., Shin, D. M., Cohen, R. B., Jones, C. U., Sur, R., Raben, D., Jassem, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053422 · Cited by 5,115
Argiris, A., Karamouzis, M. V., Raben, D., & Ferris, R. L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60728-x · Cited by 2,224
HPV-associated head and neck cancer: a virus-related cancer epidemic
Marur, S., D'Souza, G., Westra, W. H., & Forastiere, A. A. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70017-6 · Cited by 1,816
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
Posner, M. R., Hershock, D. M., Blajman, C. R., Mickiewicz, E., Winquist, E., Gorbounova, V., Tjulandin, S., Shin, D. M., Cullen, K., Ervin, T. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070956 · Cited by 1,705
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Metadata
- Authors
- Denis, F., Garaud, P., Bardet, E., Alfonsi, M., Sire, C., Germain, T., Bergerot, P., Rhein, B., Tortochaux, J., & Calais, G.
- Venue
- Journal of Clinical Oncology
- Published
- 2004-01-01
- Volume
- 22
- Issue
- 1
- Pages
- 69-76
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2172200669
- Cited by
- 900
- References
- 20
- FWCI
- 34.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.